Literature DB >> 29296303

Estimating normal tissue toxicity in radiosurgery of the CNS: application and limitations of QUANTEC.

John P Kirkpatrick1, Lawrence B Marks2, Charles S Mayo3, Yaacov R Lawrence4, Niranjan Bhandare5, Samuel Ryu6.   

Abstract

Minimizing radiation-induced normal tissue damage in the central nervous system (CNS) is a key objective and primary impetus for stereotactic radiosurgery and radiotherapy. The recently published Quantitative Analysis of Normal Tissue Effects in the Clinic (QUANTEC) study provides updated dose/volume/ outcome data on normal tissue tolerance for sixteen anatomic sites, including the CNS. Most of the data used to develop the relationship between dose, volume and normal tissue toxicity derived from large field, conventionally fractionated regimens, and quantitative dose/volume/outcome data at high doses per fraction to limited volumes is much sparser. Nonetheless, QUANTEC provides some limited recommendations for dose constraints in stereotactic radiosurgery/ radiotherapy of the CNS. This paper critically reviews the findings, recommendations and limitations of QUANTEC as they apply to radiosurgery of the CNS, as well as presenting suggestions to establish and validate clinically meaningful dose/volume/toxicity relationships in this setting.

Entities:  

Keywords:  Auditory apparatus; Brain; Brainstem; Central nervous system; Hearing; Hypofractionated stereotactic radiotherapy; Myelopathy; Normal tissue toxicity; Optic apparatus; Radiation-induced optic neuropathy; Spine; Stereotactic radiosurgery

Year:  2011        PMID: 29296303      PMCID: PMC5675466     

Source DB:  PubMed          Journal:  J Radiosurg SBRT


  81 in total

1.  Reliability analysis of the epidural spinal cord compression scale.

Authors:  Mark H Bilsky; Ilya Laufer; Daryl R Fourney; Michael Groff; Meic H Schmidt; Peter Paul Varga; Frank D Vrionis; Yoshiya Yamada; Peter C Gerszten; Timothy R Kuklo
Journal:  J Neurosurg Spine       Date:  2010-09

2.  Cell-survival probability at large doses: an alternative to the linear-quadratic model.

Authors:  L G Hanin; M Zaider
Journal:  Phys Med Biol       Date:  2010-07-30       Impact factor: 3.609

3.  Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone.

Authors:  Hidefumi Aoyama; Masao Tago; Norio Kato; Tatsuya Toyoda; Masahiro Kenjyo; Saeko Hirota; Hiroki Shioura; Taisuke Inomata; Etsuo Kunieda; Kazushige Hayakawa; Keiichi Nakagawa; Gen Kobashi; Hiroki Shirato
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-08-01       Impact factor: 7.038

4.  The integral biologically effective dose to predict brain stem toxicity of hypofractionated stereotactic radiotherapy.

Authors:  B G Clark; L Souhami; C Pla; A S Al-Amro; J P Bahary; J G Villemure; J L Caron; A Olivier; E B Podgorsak
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-02-01       Impact factor: 7.038

5.  Partial volume tolerance of the spinal cord and complications of single-dose radiosurgery.

Authors:  Samuel Ryu; Jian-Yue Jin; Ryan Jin; Jack Rock; Munther Ajlouni; Benjamin Movsas; Mark Rosenblum; Jae Ho Kim
Journal:  Cancer       Date:  2007-02-01       Impact factor: 6.860

6.  Image-guided robotic stereotactic body radiotherapy for benign spinal tumors: theUniversity of California San Francisco preliminary experience.

Authors:  A Sahgal; D Chou; C Ames; L Ma; K Lamborn; K Huang; C Chuang; A Aiken; P Petti; P Weinstein; D Larson
Journal:  Technol Cancer Res Treat       Date:  2007-12

7.  Fractionated stereotactic radiotherapy for acoustic neuromas.

Authors:  Jeffery A Williams
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-10-01       Impact factor: 7.038

8.  Tumor response to radiotherapy regulated by endothelial cell apoptosis.

Authors:  Monica Garcia-Barros; Francois Paris; Carlos Cordon-Cardo; David Lyden; Shahin Rafii; Adriana Haimovitz-Friedman; Zvi Fuks; Richard Kolesnick
Journal:  Science       Date:  2003-05-16       Impact factor: 47.728

9.  Brain stem metastases treated with radiosurgery: prognostic factors of survival and life expectancy estimation.

Authors:  José G Lorenzoni; Daniel Devriendt; Nicolas Massager; Françoise Desmedt; Stéphane Simon; Paul Van Houtte; Jacques Brotchi; Marc Levivier
Journal:  Surg Neurol       Date:  2008-04-24

Review 10.  Radiation response of the central nervous system.

Authors:  T E Schultheiss; L E Kun; K K Ang; L C Stephens
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-03-30       Impact factor: 7.038

View more
  11 in total

1.  Determining normal tissue dose in intracranial stereotactic radiosurgery: A diameter-based predictive nomogram.

Authors:  Donal Cummins; Siobhra O'Sullivan; Mary Dunne; Ronan McDermott; Maeve Keys; David Fitzpatrick; Clare Faul; Mohsen Javadpour; Christina Skourou
Journal:  J Radiosurg SBRT       Date:  2020

2.  The radiosurgery fractionation quandary: single fraction or hypofractionation?

Authors:  John P Kirkpatrick; Scott G Soltys; Simon S Lo; Kathryn Beal; Dennis C Shrieve; Paul D Brown
Journal:  Neuro Oncol       Date:  2017-04-01       Impact factor: 12.300

3.  The Incidence and Its Associated Factors Relevant to Brain Radionecrosis That Requires Intervention Following Single or Fractionated Stereotactic Radiosurgery Using Vero4DRT for Brain Metastases.

Authors:  Takehiro Yamada; Kazuhiro Ohtakara; Takeshi Kamomae; Junji Itoh; Hideki Shimada; Shunichi Ishihara; Shinji Naganawa
Journal:  Cureus       Date:  2022-06-13

Review 4.  [Normal tissue: radiosensitivity, toxicity, consequences for planning].

Authors:  A Rühle; P E Huber
Journal:  Radiologe       Date:  2018-08       Impact factor: 0.635

5.  Neoadjuvant stereotactic radiosurgery for intracerebral metastases of solid tumors (NepoMUC): a phase I dose escalation trial.

Authors:  Christian D Diehl; Ehab Shiban; Christoph Straube; Jens Gempt; Jan J Wilkens; Markus Oechsner; Carmen Kessel; Claus Zimmer; Benedict Wiestler; Bernhard Meyer; Stephanie E Combs
Journal:  Cancer Commun (Lond)       Date:  2019-11-09

Review 6.  Current status and recent advances in reirradiation of glioblastoma.

Authors:  Giuseppe Minniti; Maximilian Niyazi; Filippo Alongi; Piera Navarria; Claus Belka
Journal:  Radiat Oncol       Date:  2021-02-18       Impact factor: 3.481

7.  Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy for Nonfunctioning Pituitary Adenoma.

Authors:  Mohamed H Khattab; Alexander D Sherry; Mark C Xu; Patrick Kelly; Joshua L Anderson; Guozhen Luo; Lola B Chambless; Anthony J Cmelak; Albert Attia
Journal:  J Neurol Surg B Skull Base       Date:  2020-05-05

8.  Survival of rats bearing advanced intracerebral F 98 tumors after glutathione depletion and microbeam radiation therapy: conclusions from a pilot project.

Authors:  E Schültke; E Bräuer-Krisch; H Blattmann; H Requardt; J A Laissue; G Hildebrandt
Journal:  Radiat Oncol       Date:  2018-05-10       Impact factor: 3.481

9.  The Role of Navigated Transcranial Magnetic Stimulation Motor Mapping in Adjuvant Radiotherapy Planning in Patients With Supratentorial Brain Metastases.

Authors:  Maximilian J Schwendner; Nico Sollmann; Christian D Diehl; Markus Oechsner; Bernhard Meyer; Sandro M Krieg; Stephanie E Combs
Journal:  Front Oncol       Date:  2018-10-02       Impact factor: 6.244

10.  Combinatorial Anatomic and Functional Neural Tract Mapping for Stereotactic Radiosurgery Planning.

Authors:  Robert A Scranton; Kuan Yin Hsiao; Saeed S Sadrameli; Hui-Chuan Wang; Yvonne Thong; Patricia Garcia Luzardo; Steve H Fung; Ramiro Pino; Andrew M Farach; E Brian Butler; Bin Teh; Robert C Rostomily
Journal:  Cureus       Date:  2019-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.